Combination therapy with toripalimab and anlotinib in advanced esophageal squamous cell carcinoma: A case report.

Chen, Si-Cong; Ma, Dong-Heng; Zhong, Jia-Jian

Chen, Si-Cong; Ma, Dong-Heng; Zhong, Jia-Jian.

Afiliación

Chen SC; Hepatobiliary and Pancreatic Surgery, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518052, Guangdong Province, China.
Ma DH; Hepatobiliary and Pancreatic Surgery, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518052, Guangdong Province, China.
Zhong JJ; Hepatobiliary and Pancreatic Surgery, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518052, Guangdong Province, China. jjzhong11@163.com.

World J Clin Cases ; 11(27): 6579-6586, 2023 Sep 26.

Article en En | MEDLINE | ID: mdl-37900244

Palabras clave

Anlotinib; Case report; Complete response; Esophageal squamous cell carcinoma; Toripalimab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: World J Clin Cases Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google